Development of EBC46 for human tumors

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1017676

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

EBC46 is a novel compound from the rain forest, being developed for cancer treatment by QBiotics Ltd and Queensland Institute of Medical Research. Injection of EBC46 into tumors in 5 different animal species rapidly destroyed the tumor, with good healing and no adverse effects. EBC46 therefore has potential for local control, perhaps cure, of a wide range of tumor types in humans.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2012

Funding Scheme: NHMRC Development Grants

Funding Amount: $260,668.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical and Health Sciences

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

There are no Other Keywords available for this funding activity

Related Links

ACN 633 798 857